All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| ENTA / Enanta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| US462222AB68 / Ionis Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| HIMS / Hims & Hers Health, Inc.
|
|
|
|
|
|
|
|
| NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
| CSTL / Castle Biosciences, Inc.
|
|
|
|
|
|
|
|
| AFMD / Affimed N.V.
|
|
|
|
|
|
|
|
| LRMR / Larimar Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TARA / Protara Therapeutics, Inc.
|
|
|
|
|
|
|
|
| OSH / Oak Street Health Inc
|
|
|
|
|
|
|
|
| US38341PAA03 / Gossamer Bio Inc
|
|
|
|
|
|
|
|
| LNTH / Lantheus Holdings, Inc.
|
|
|
|
|
|
|
|
| RVNC / Revance Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MDNA / Medicenna Therapeutics Corp
|
|
|
|
|
|
|
|
| BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|
| IONS / Ionis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| DVAX / Dynavax Technologies Corporation
|
|
|
|
|
|
|
|
| MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
| PRVB / Provention Bio Inc
|
|
|
|
|
|
|
|
| MRSN / Mersana Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ZYME / Zymeworks Inc.
|
|
|
|
|
|
|
|
| NVRO / Nevro Corp.
|
|
|
|
|
|
|
|
| EIGR / Eiger BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| HARP / Harpoon Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ONCR / Oncorus, Inc.
|
|
|
|
|
|
|
|
| KDMN / Kadmon Holdings Inc
|
|
|
|
|
|
|
|
| IRTC / iRhythm Technologies, Inc.
|
|
|
|
|
|
|
|
| QDEL / QuidelOrtho Corporation
|
|
|
|
|
|
|
|
| AXNX / Axonics, Inc.
|
|
|
|
|
|
|
|
| US92538T1043 / VESPER HEALTHCARE ACQUISITION CORP A
|
|
|
|
|
|
|
|
| TPTX / Turning Point Therapeutics Inc
|
|
|
|
|
|
|
|
| BHVN / Biohaven Ltd.
|
|
|
|
|
|
|
|
| US2103731061 / Constellation Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| STAA / STAAR Surgical Company
|
|
|
|
|
|
|
|
| RFL / Rafael Holdings, Inc.
|
|
|
|
|
|
|
|
| AXGN / Axogen, Inc.
|
|
|
|
|
|
|
|
| SRDX / Surmodics, Inc.
|
|
|
|
|
|
|
|
| NVTA / Invitae Corporation
|
|
|
|
|
|
|
|
| XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
|
|
|
|
|
|
|
|
| MSON / Misonix Inc
|
|
|
|
|
|
|
|
| KYMR / Kymera Therapeutics, Inc.
|
|
|
|
|
|
|
|
| US0153511094 / Alexion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| HIMS / Hims & Hers Health, Inc.
|
|
|
|
|
|
|
|
| / Immunomedics, Inc.
|
|
|
|
|
|
|
|
| MRK / Merck & Co., Inc.
|
|
|
|
|
|
|
|
| PCRX / Pacira BioSciences, Inc.
|
|
|
|
|
|
|
|
| DRIO / DarioHealth Corp.
|
|
|
|
|
|
|
|
| COGT / Cogent Biosciences, Inc.
|
|
|
|
|
|
|
|
| HZNP / Horizon Therapeutics Plc
|
|
|
|
|
|
|
|
| ARNA / Arena Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| EXEL / Exelixis, Inc.
|
|
|
|
|
|
|
|
| CRDF / Cardiff Oncology, Inc.
|
|
|
|
|
|
|
|
| TCRR / Tcr2 Therapeutics Inc
|
|
|
|
|
|
|
|
| PAYX / Paychex, Inc.
|
|
|
|
|
|
|
|
| OSUR / OraSure Technologies, Inc.
|
|
|
|
|
|
|
|
| CRSP / CRISPR Therapeutics AG
|
|
|
|
|
|
|
|
| NVCR / NovoCure Limited
|
|
|
|
|
|
|
|
| DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
| TRIL / Trillium Therapeutics Inc
|
|
|
|
|
|
|
|
| PIRS / Pieris Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| NEO / NeoGenomics, Inc.
|
|
|
|
|
|
|
|
| FATE / Fate Therapeutics, Inc.
|
|
|
|
|
|
|
|
| GLTO / Galecto, Inc.
|
|
|
|
|
|
|
|
| SPRY / ARS Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ZYXI / Zynex, Inc.
|
|
|
|
|
|
|
|
| CCCC / C4 Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ADVM / Adverum Biotechnologies, Inc.
|
|
|
|
|
|
|
|
| ABBV / AbbVie Inc.
|
|
|
|
|
|
|
|
| INBX / Inhibrx Biosciences, Inc.
|
|
|
|
|
|
|
|
| BIIB / Biogen Inc.
|
|
|
|
|
|
|
|
| KRYS / Krystal Biotech, Inc.
|
|
|
|
|
|
|
|
| AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| VCEL / Vericel Corporation
|
|
|
|
|
|
|
|
| ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
| BCAB / BioAtla, Inc.
|
|
|
|
|
|
|
|
| PODD / Insulet Corporation
|
|
|
|
|
|
|
|
| EPIX / ESSA Pharma Inc.
|
|
|
|
|
|
|
|
| VRDN / Viridian Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ESTA / Establishment Labs Holdings Inc.
|
|
|
|
|
|
|
|
| ALPN / Alpine Immune Sciences, Inc.
|
|
|
|
|
|
|
|
| SRRK / Scholar Rock Holding Corporation
|
|
|
|
|
|
|
|
| IRMD / IRADIMED CORPORATION
|
|
|
|
|
|
|
|
| XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| LYRA / Lyra Therapeutics, Inc.
|
|
|
|
|
|
|
|
